$NBIO - Nascent CEO Sean Carrick remarked, "We are pleased to be featured in this independent prospective of Nascent's investment potential. This report underscores our internal conviction that the Company's common stock is presently undervalued." https://finance.yahoo.com/news/nascent-biotech-receives-analyst-opinion-130000256.html